Ad
related to: what is the fda stand for
Search results
FDA Gets Technical on HCT/P Rules in Warning Letter to Human Tissue Company | JD Supra
JD Supra· 16 hours agoOn May 21, 2024, the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA) published a warning letter issued to Akan Biosciences ...
A Major Cucumber Recall Has Been Issued—Here's What You Need to Know
Parade via Yahoo News· 8 hours agoThey are reportedly all dark green in color, between five and nine inches long, and one and a half...
6 major Supreme Court rulings to watch for in June
Deseret News via Yahoo News· 3 days agoThe judgment of the Colorado Supreme Court therefore cannot stand,” the court’s per curiam ruling, which was released on March 4, said. And just last...
DexCom maintains $150 target amid new FDA approval By Investing.com
Investing.com· 5 hours agoThe firm's stance comes in light of recent developments in the CGM market, with rival Abbott (ABT)...
Ozempic Patients Say It Changes How Food Tastes, and Science Now Has an Answer — Best Life
Best Life· 7 hours agoWhile it's only approved by the U.S. Food and Drug Administration (FDA) for the treatment of type 2...
20 Stars Who've Spoken About Ozempic and Other Weight-Loss Drugs
SheKnows via Yahoo News· 3 days agoIt’s difficult to remember what our health landscape (and pop culture) were like before Ozempic,...
Psychedelics Have a Placebo Problem
The Atlantic· 4 hours agoAdministration advisory committee will meet to discuss whether the United States should approve its first psychedelic drug. The fate of the...
Psychoactive drugs are having a moment. The FDA will soon weigh in
The State· 15 hours agoPsychoactive drugs are having a moment. Investors are piling into the nascent field, and a host of medications based on MDMA, LSD, psychedelic mushrooms, ketamine, the South American plant mixture ...
FDA staff questions safety of ecstasy for PTSD
Axios· 3 days agoWhy it matters: The findings cast new doubts on what could become the first psychedelic-based treatment approved in the U.S. ahead of a June 4 meeting...
FDA sets review date for Iterum's urinary infection drug By Investing.com
Investing.com· 3 days agoIterum Therapeutics plc (NASDAQ:ITRM), a clinical-stage pharmaceutical company, announced today that...
